MODULATOREN DER BMI-1-PROTEINEXPRESSION

Patent europeic · EP3111956 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3111956
Numer da la dumonda
EP16178291
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
01-07-2009
Publitgà
04-01-2017
Concedì
08-05-2019
Stritgà
31-07-2019
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 45/06 (2006.01)
A61K 31/425 (2006.01)
C07D 487/04 (2006.01)
Prioritad
US 77367 01.07.2008
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 19-02-2020

    Stritgà, taxa betg pajada

    Published in Swissreg on 19.02.2020

  2. 08-05-2019

    Concedì

    Published in Swissreg on 08.05.2019

Partidas

Possessur

PTC Therapeutics, Inc.

100 Corporate Court, Middlesex Business Center, South Plainfield, NJ 07080, US

Inventur

DAVIS, Thomas

South Orange, NJ New Jersey 07079, US

MEDINA, Daniel, J.

Hampton, NJ New Jersey 08827, US

CAO, Liangxian

Parlin, NJ New Jersey 08859, US

MOON, Young-Choon

Belle Mead, NJ New Jersey 08502, US

SYDORENKO, Nadiya

Princeton, New Jersey 08540, US

RAFANAN, Marites, A.

Woodbridge, NJ New Jersey 07095, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.